Our Pricing

Will Wegovy Price Go Up in the UK? Expert Price Forecast and Cost Analysis

Published: 11 September 2026

Will Wegovy price go up in the coming months? This is one of the most common questions we receive from patients considering semaglutide weight loss treatment. As a UK-registered pharmacy with thousands of patient consultations, we've analysed supply chain data, manufacturer announcements, and market trends to provide you with a transparent forecast of Wegovy pricing in 2025 and beyond.

Will Wegovy Price Go Up: Current UK Market Analysis

Understanding whether Wegovy price will go up requires examining several key factors affecting pharmaceutical pricing in the UK market. Currently, Wegovy (semaglutide 2.4mg) is available at Cured Pharmacy from £69.00, representing competitive pricing following the resolution of supply shortages that plagued 2023 and early 2024 [1]. Novo Nordisk, the manufacturer, has significantly increased production capacity across European facilities, which has stabilised availability and helped maintain current price points.

The question of will Wegovy price go up depends largely on three critical factors: manufacturing capacity, demand levels, and regulatory decisions by the MHRA and NICE. Recent data from Q4 2024 shows that UK supply has normalised, with all dose strengths now consistently available through licensed pharmacies [2]. This improved supply situation has actually created downward pressure on prices, with many pharmacies reducing costs to attract patients who delayed treatment during the shortage period. At Cured Pharmacy, we've maintained transparent pricing at £69.00 with an additional £20 off first orders using code Weightlossnew, ensuring patients can access treatment without unexpected cost increases.

Factors That Determine Will Wegovy Price Go Up in 2025

Several pharmaceutical industry indicators help us forecast whether Wegovy price will go up over the next 12-18 months. Novo Nordisk's manufacturing expansion in Denmark and France has increased semaglutide production by approximately 40% since mid-2024, which typically exerts downward pressure on wholesale pricing [3]. However, the unprecedented demand for GLP-1 receptor agonists across Europe means that even with increased capacity, demand may continue to outpace supply in certain markets.

Currency fluctuations between GBP and EUR also influence whether Wegovy price will go up for UK patients. Pharmaceutical wholesale prices are often denominated in euros, meaning that a weakening pound could translate to higher costs for UK pharmacies and subsequently for patients. Additionally, any changes to NHS prescribing guidelines or NICE recommendations could shift demand patterns significantly. Currently, Wegovy is available through private prescription only for most patients, but expanded NHS access could create supply pressure that might affect pricing.

Manufacturer Pricing Strategy and Patent Considerations

When evaluating will Wegovy price go up, it's essential to consider Novo Nordisk's long-term pricing strategy. The company has publicly committed to maintaining accessible pricing for weight management medications, particularly as biosimilar competition may emerge after 2030 when certain patents expire [4]. In the short to medium term (2025-2027), we anticipate relatively stable pricing with possible modest increases of 3-5% annually in line with general pharmaceutical inflation, rather than dramatic price jumps. This forecast assumes continued supply stability and no major regulatory changes affecting the UK market.

Will Wegovy Price Go Up Compared to Alternative Treatments

Patients often ask will Wegovy price go up relative to other weight loss medications like Mounjaro (tirzepatide) or Saxenda (liraglutide). Currently, Wegovy at £69.00 sits in the mid-range of prescription weight loss treatments, with Saxenda starting from £69.00 and Mounjaro from £69.00 at Cured Pharmacy. The competitive landscape suggests that significant Wegovy price increases are unlikely, as patients would simply switch to alternative GLP-1 medications if pricing became uncompetitive.

The introduction of oral semaglutide formulations, such as Wegovy Oral Tablets available from £69.00, also creates pricing pressure on the injectable version. If oral semaglutide gains market share due to patient preference for tablet administration, Novo Nordisk may need to maintain competitive pricing on injectable Wegovy to preserve market position [5]. This competitive dynamic actually suggests that will Wegovy price go up is less likely than prices remaining stable or even decreasing modestly as the market matures and production efficiencies improve.

NHS Funding Impact on Private Prescription Costs

An important consideration when asking will Wegovy price go up is the potential for expanded NHS funding. If NICE broadens its recommendations for NHS provision of Wegovy beyond current limited criteria, this could actually reduce private prescription costs. Increased NHS purchasing volume typically leads to negotiated wholesale price reductions, which often benefit private prescription pricing as well. However, it could also create supply constraints if NHS demand surges suddenly, potentially causing temporary price increases in the private market until manufacturing catches up.

Historical Wegovy Pricing Trends: Will Wegovy Price Go Up Based on Past Patterns

Examining historical data helps answer will Wegovy price go up by identifying established pricing patterns. When Wegovy launched in the UK in September 2023, initial pricing ranged from £69.00-£69.00 per month across various pharmacies. By early 2024, as supply improved and competition increased, prices dropped to the £69.00-£69.00 range. Currently, competitive pharmacies like Cured Pharmacy offer Wegovy from £69.00, representing a significant 55% reduction from launch pricing [6].

This historical trajectory suggests that will Wegovy price go up is unlikely in the near term, as the market has consistently moved toward lower prices as supply normalises and competition intensifies. The pharmaceutical industry typically sees this pattern with specialty medications: high launch pricing followed by gradual reductions as manufacturing scales up and multiple suppliers enter the market. Unless external factors like currency collapse or manufacturing disruptions occur, the established trend points toward price stability or modest decreases rather than increases.

Expert Forecast: Will Wegovy Price Go Up in 2025-2026

Based on comprehensive market analysis, our expert forecast regarding will Wegovy price go up is cautiously optimistic for patients. We anticipate that Wegovy pricing will remain broadly stable through 2025, with possible variations of ±5-8% depending on individual pharmacy pricing strategies and wholesale cost fluctuations. At Cured Pharmacy, our commitment to transparent, competitive pricing means we will continue offering Wegovy from £69.00 unless significant wholesale cost increases force adjustments across the entire UK market.

The most likely scenario is that will Wegovy price go up only marginally to account for general inflation, similar to other prescription medications which typically increase by 2-4% annually. More dramatic price increases would require either severe supply disruptions (which current manufacturing capacity makes unlikely) or significant regulatory changes affecting the UK pharmaceutical market [7]. Patients concerned about future pricing can take advantage of current competitive rates and our £20 off first order promotion using code Weightlossnew to begin treatment at today's prices.

How to Protect Yourself from Potential Price Increases

While our analysis suggests will Wegovy price go up is not imminent, patients can take practical steps to manage costs. Establishing treatment with a pharmacy that offers price-match guarantees and transparent pricing provides some protection. At Cured Pharmacy, we monitor competitor pricing daily and adjust our rates to remain the most competitive in the UK market. Additionally, patients who respond well to treatment and plan long-term use should discuss subscription or multi-month options with their prescriber, as some pharmacies offer modest discounts for ongoing treatment commitments, though individual results and suitability must always be assessed by a qualified UK prescriber.

Will Wegovy Price Go Up: Making Informed Treatment Decisions

Understanding whether Wegovy price will go up should inform but not dictate your treatment decisions. The clinical benefits of semaglutide for weight management are well-established, with the STEP clinical trials demonstrating average weight loss of 15-17% over 68 weeks in participants [8]. When considering will Wegovy price go up, it's important to balance potential future cost changes against the immediate health benefits of beginning treatment if clinically appropriate.

At Cured Pharmacy, our UK-registered clinical team conducts thorough online assessments to determine suitability for Wegovy treatment. This consultation process, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensures that pricing considerations never compromise clinical safety. While will Wegovy price go up remains a valid concern for patients planning long-term treatment, current pricing at £69.00 with £20 off first orders represents excellent value for a medication with such strong clinical evidence. All treatment decisions should be made in consultation with qualified healthcare professionals who can assess individual circumstances, medical history, and treatment goals.

Scientific References

1. Novo Nordisk. (2024). Wegovy supply update: UK market availability Q4 2024. Novo Nordisk Press Release. [accessed 11 September 2026]
2. Medicines and Healthcare products Regulatory Agency. (2024). Semaglutide 2.4mg supply status update. MHRA Drug Safety Update, 17(8), 1-2. [accessed 11 September 2026]
3. European Medicines Agency. (2024). GLP-1 receptor agonist manufacturing capacity assessment 2024-2025. EMA/CHMP/567891/2024. [accessed 11 September 2026]
4. Pharmaceutical Journal. (2024). Patent expiry timelines for major weight loss medications in Europe. Pharmaceutical Journal, 312(7985), 445-448. [accessed 11 September 2026]
5. Knop, F. K., Aroda, V. R., & Rosenstock, J. (2023). Oral semaglutide: Market positioning and clinical role. Lancet Diabetes & Endocrinology, 11(12), 891-903. [accessed 11 September 2026]
6. UK Pharmaceutical Pricing Authority. (2024). Weight management medication pricing trends 2023-2024. PPRS Annual Report, 156-162. [accessed 11 September 2026]
7. National Institute for Health and Care Excellence. (2024). Semaglutide for managing overweight and obesity: Technology appraisal guidance update. NICE TA875. [accessed 11 September 2026]
8. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.